TIVA and VIMA on Blood Glucose and Insulin Levels in Lung Lobectomy Patients
Hyperglycemia Stress
About this trial
This is an interventional prevention trial for Hyperglycemia Stress focused on measuring Anesthesia, intravenous, Anesthesia, inhalation, propofol, sevoflurane, glucose
Eligibility Criteria
Inclusion Criteria:
- Non-diabetic patients American Society of Anesthesiologist Physical Status Classification 1 - 3
Exclusion Criteria:
- Diabetes mellitus or glucose intolerance patients, patients with adrenocortical hormone metabolism abnormality, patients with steroids therapy within the last month, patients with liver disease (aspartate aminotransferase> 40 IU / L or alanine aminotransferase> 40 IU / L), patients with kidney disease (creatinine 1.5 mg / dl), pregnant woman, patients with hypersensitivity to anesthetics used in research, patients who required ventilator care after surgery
Sites / Locations
- Yeungnam University Hospital
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Total intravenous anesthesia
volatileinduction maintenance anesthesia
In the total intravenous anesthesia(TIVA) group, target controlled infusion (TCI) I was performed with propofol 4 mcg / ml. When the consciousness of the patient is lost, Remifentanil is administered as TCI with a target concentration of 1 ng / ml as an analgesic agent, and rocuronium 0.5 mg / kg is administered intravenously for intubation.
In the volatile induction and maintenance anesthesia(VIMA) group, when 8% sevoflurane is inhaled with 100% oxygen at 6 L / min and the consciousness is lost, the concentration of sevoflurane is reduced to 2-3% and then the mask is ventilated.Remifentanil is administered as TCI with a target concentration of 1 ng / ml as an analgesic agent, and rocuronium 0.5 mg / kg is administered intravenously for intubation.